Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
1.680
+0.050 (3.07%)
At close: Oct 22, 2024, 4:00 PM
1.670
-0.010 (-0.60%)
After-hours: Oct 22, 2024, 7:59 PM EDT

Virax Biolabs Group Balance Sheet

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Cash & Equivalents
3.593.599.350.020.020.02
Short-Term Investments
0.080.080.050.01--
Cash & Short-Term Investments
3.673.679.40.030.020.02
Cash Growth
-61.00%-61.00%33774.24%57.51%-22.06%-
Accounts Receivable
----0-
Other Receivables
0.220.22----
Receivables
0.220.22--0-
Inventory
0.310.310.020.020.02-
Prepaid Expenses
0.190.190.21---
Total Current Assets
4.384.389.630.050.040.02
Property, Plant & Equipment
1.051.05----
Other Intangible Assets
0.050.050.18---
Total Assets
5.485.489.810.050.040.02
Accounts Payable
0.050.050.160.850.220.21
Accrued Expenses
0.080.080.550.40.460.25
Short-Term Debt
--0.16-0.180.76
Current Portion of Leases
0.050.05----
Current Unearned Revenue
--0.04---
Other Current Liabilities
---00.020.02
Total Current Liabilities
0.170.170.911.250.871.24
Long-Term Leases
0.180.18----
Total Liabilities
0.350.350.911.250.871.24
Common Stock
000000
Retained Earnings
-18.53-18.53-11.79-6.34-4.63-3.98
Comprensive Income & Other
23.8923.8920.925.363.982.92
Total Common Equity
5.375.379.13-0.97-0.65-1.06
Minority Interest
-0.23-0.23-0.22-0.22-0.18-0.16
Shareholders' Equity
5.145.148.9-1.2-0.83-1.22
Total Liabilities & Equity
5.485.489.810.050.040.02
Total Debt
0.220.220.16-0.180.76
Net Cash (Debt)
3.443.449.240.03-0.16-0.73
Net Cash Growth
-62.73%-62.73%33181.39%---
Net Cash Per Share
1.721.728.690.03-0.66-7.02
Filing Date Shares Outstanding
2.572.571.79110.1
Total Common Shares Outstanding
2.572.571.5510.920.1
Working Capital
4.214.218.73-1.2-0.83-1.22
Book Value Per Share
2.092.095.87-0.98-0.70-10.12
Tangible Book Value
5.325.328.95-0.97-0.65-1.06
Tangible Book Value Per Share
2.072.075.76-0.98-0.70-10.12
Machinery
0.90.90.01---
Source: S&P Capital IQ. Standard template. Financial Sources.